Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Viking has long been viewed as a takeover target, given the positive data from early VK2735 trials. The company’s most recent ...

Shares of Dogwood Therapeutics Inc. rose over 18% in premarket trading Friday, following a jaw-dropping 370% surge in the ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

The biotech market offers great investment potential due to innovative advancements in genetic profiling, biologics, CRISPR ...

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest ...

It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

Shares of Summit Therapeutics ( SMMT 4.80%) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after reports ...